Evidence map›Paper›PMID 33024146›Full record

ArticleScientific reports2020

A novel speculum-free imaging strategy for visualization of the internal female lower reproductive system.

Mercy N Asiedu, Júlia S Agudogo, Mary E Dotson, Erica Skerrett, Marlee S Krieger, Christopher T Lam, Doris Agyei, Juliet Amewu, Kwaku Asah-Opoku, Megan Huchko and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00900575 (Cervical Cancer Detection Using Optical Spectroscopy), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00900575 narecruitingnot on this map

Cervical Cancer Detection Using Optical Spectroscopy

TypeinterventionalSponsorDuke UniversityRan2006 to 2028Enrolled350ConditionsCervical CancerArmsOptical Spectroscopy Bench-Top System, Portable Optical Spectrometer, Transvaginal colposcope
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Speculum-free portable preterm imaging system.Journal of biomedical optics · 2024
    Article
  5. A Comprehensive Review of Cervical Cancer Screening Devices: The Pros and the Cons.Asian Pacific journal of cancer prevention : APJCP · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Mercy N AsieduDepartment of Biomedical Engineering, Duke University, Gross Hall Rm 370, Durham, NC, 27713, USA. mercynasiedu@gmail.com.
Júlia S AgudogoDepartment of Biomedical Engineering, Duke University, Gross Hall Rm 370, Durham, NC, 27713, USA.
Mary E DotsonCenter for Global Women's Health Technologies, Duke University, Durham, NC, USA.
Erica SkerrettDepartment of Biomedical Engineering, Duke University, Gross Hall Rm 370, Durham, NC, 27713, USA.
Marlee S KriegerDepartment of Biomedical Engineering, Duke University, Gross Hall Rm 370, Durham, NC, 27713, USA.
Christopher T LamDepartment of Biomedical Engineering, Duke University, Gross Hall Rm 370, Durham, NC, 27713, USA.
Doris AgyeiFamily Planning and Reproductive Health Unit, Greater Accra Regional Hospital, Accra, Ghana.
Juliet AmewuFamily Planning and Reproductive Health Unit, Greater Accra Regional Hospital, Accra, Ghana.
Kwaku Asah-OpokuDepartment of Obstetrics and Gynecology, Korle Bu Teaching Hospital, Accra, Ghana.
Megan HuchkoDuke Global Health Institute, Duke University, Durham, NC, USA.
John W SchmittDuke Global Health Institute, Duke University, Durham, NC, USA.
Ali SambaDepartment of Obstetrics and Gynecology, Korle Bu Teaching Hospital, Accra, Ghana.
Emmanuel SrofenyohFamily Planning and Reproductive Health Unit, Greater Accra Regional Hospital, Accra, Ghana.
Nirmala RamanujamDepartment of Biomedical Engineering, Duke University, Gross Hall Rm 370, Durham, NC, 27713, USA.
Duke Institute for Health Innovation · USDuke University · USGhana Health Service · GHKorle Bu Teaching Hospital · GHUniversity of Ghana · GH

Funding

Novel see and treat strategies for cervical cancer prevention in low-resource settingsR01CA239268 · NCI · DUKE UNIVERSITY · PI KATZ, DAVID FRANK, RAMANUJAM, NIRMALA · 2019 to 2023
$3.1M
Culturally appropriate screening and diagnosis of cervical cancer in East AfricaR01CA193380 · NCI · DUKE UNIVERSITY · PI RAMANUJAM, NIRMALA · 2015 to 2019
$2.9M
A Viable Solution for a See and Treat Paradigm for Cervical Pre-cancer in AfricaR01CA195500 · NCI · DUKE UNIVERSITY · PI RAMANUJAM, NIRMALA · 2015 to 2017
$647k
NCI NIH HHS R01 CA193380NCI NIH HHS R01 CA195500NCI NIH HHS R01 CA239268NIH HHS 5R01CA193380-05
6 · The paper itself

Abstract

Fear of the speculum and feelings of vulnerability during the gynecologic exams are two of the biggest barriers to cervical cancer screening for women. To address these barriers, we have developed a novel, low-cost tool called the Callascope to reimagine the gynecological exam, enabling clinician and self-imaging of the cervix without the need for a speculum. The Callascope contains a 2 megapixel camera and contrast agent spray mechanism housed within a form factor designed to eliminate the need for a speculum during contrast agent administration and image capture. Preliminary bench testing for comparison of the Callascope camera to a $20,000 high-end colposcope demonstrated that the Callascope camera meets visual requirements for cervical imaging. Bench testing of the spray mechanism demonstrates that the contrast agent delivery enables satisfactory administration and cervix coverage. Clinical studies performed at Duke University Medical Center, Durham, USA and in Greater Accra Regional Hospital, Accra, Ghana assessed (1) the Callascope's ability to visualize the cervix compared to the standard-of-care speculum exam, (2) the feasibility and willingness of women to use the Callascope for self-exams, and (3) the feasibility and willingness of clinicians and their patients to use the Callascope for clinician-based examinations. Cervix visualization was comparable between the Callascope and speculum (83% or 44/53 women vs. 100%) when performed by a clinician. Visualization was achieved in 95% (21/22) of women who used the Callascope for self-imaging. Post-exam surveys indicated that participants preferred the Callascope to a speculum-based exam. Our results indicate the Callascope is a viable option for clinician-based and self-exam speculum-free cervical imaging.Clinical study registration ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/record/ NCT00900575, Pan African Clinical Trial Registry (PACTR) https://www.pactr.org/ PACTR201905806116817.

Indexed as

Cervix UteriEarly Detection of CancerFemaleGhanaGynecological ExaminationHumansSelf-ExaminationUnited StatesUterine Cervical Neoplasms

Identifiers

PMID33024146
PMCPMC7538883
OpenAlexW3092108599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.